Category | Deals

Series B financing for $90 million for Kymab

Posted on 06 May 2015

Kymab has successfully raised an additional US$50 million to complete a US$90 million Series B financing.

Tags: , ,

EMD Serono and Pfizer in co-promotion agreement for Xalkori

Posted on 06 May 2015

EMD Serono has begun co-promoting Pfizer’s anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer.

Tags: ,

Adaptive Biotechnologies Series F financing

Posted on 05 May 2015

Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives.

Tags: ,

Series A financing for $41 million for Symbiomix

Posted on 05 May 2015

Symbiomix Therapeutics announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

Tags: ,

Pfizer in collaboration agreement for lupus study

Posted on 05 May 2015

23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer.

Tags: ,

Alexion to buy Synageva Biopharma

Posted on 05 May 2015

Alexion Pharmaceuticals have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration of $115 in cash and 0.6581 Alexion shares, for each share of Synageva, implying a total per share value of $230 based on the nine day volume-weighted average closing price of Alexion stock through May 5, 2015.

Tags: ,

Bayer and Isis in ISIS-FXIRx licensing pact

Posted on 05 May 2015

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx

Tags: , ,

Mirna Therapeutics secures $41.8mn series D

Posted on 05 May 2015

Mirna Therapeutics announced the completion of a $41.8 million Series D financing

Tags:

MyoKardia secures series B for $46 million

Posted on 05 May 2015

MyoKardia announced the successful completion of a $46 million Series B financing

Tags:

Intarcia announces $225 million synthetic royalty deal

Posted on 05 May 2015

Intarcia Therapeutics announced the closing of a $225 million synthetic royalty financing

Tags: